메뉴 건너뛰기




Volumn 47, Issue 4, 2012, Pages 488-493

Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation

Author keywords

acute myelogenous leukemia; autologous hematopoietic cell transplantation; fludarabine; follicular lymphoma; myelodysplastic syndrome

Indexed keywords

CD34 ANTIGEN; FLUDARABINE; MITOXANTRONE;

EID: 84859447672     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.109     Document Type: Article
Times cited : (33)

References (25)
  • 3
    • 0035183056 scopus 로고    scopus 로고
    • Secondary myelodysplastic syndrome after fludarabine therapy of a low-grade non-Hodgkin's lymphoma
    • DOI 10.1016/S0145-2126(00)00092-8, PII S0145212600000928
    • Misgeld E, Germing U, Aul C, Gattermann N. Secondary myelodysplastic syndrome after fludarabine therapy of a low-grade non-Hodgkin's lymphoma. Leuk Res 2001; 25: 95-98. (Pubitemid 32012986)
    • (2001) Leukemia Research , vol.25 , Issue.1 , pp. 95-98
    • Misgeld, E.1    Germing, U.2    Aul, C.3    Gattermann, N.4
  • 4
    • 0037106257 scopus 로고    scopus 로고
    • Therapy-related myeloid leukemia's are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: Results of an intergroup study, cancer and leukemia group B 9011
    • Morrison VA, Rai KR, Peterson BL, Kolitz JE, Appelbaum FR, Hines JD et al. Therapy-related myeloid leukemia's are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011. J Clin Oncol 2002; 20: 3878-3884.
    • (2002) J Clin Oncol , vol.20 , pp. 3878-3884
    • Morrison, V.A.1    Rai, K.R.2    Peterson, B.L.3    Kolitz, J.E.4    Appelbaum, F.R.5    Hines, J.D.6
  • 12
    • 33645116094 scopus 로고    scopus 로고
    • Treatment of follicular non-Hodgkin's lympho-ma
    • Maloney DG. Treatment of follicular non-Hodgkin's lympho-ma. Curr Hematol Rep 2005; 4: 39-45.
    • (2005) Curr Hematol Rep , vol.4 , pp. 39-45
    • Maloney, D.G.1
  • 13
    • 33747061875 scopus 로고    scopus 로고
    • Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia
    • DOI 10.1200/JCO.2006.06.0673
    • Kalaycio M, Rybicki L, Pohlman B, Sobecks R, Andresen S, Kuczkowski E et al. Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelo-dysplasia and acute myelogenous leukemia. J Clin Oncol 2006; 24: 3604-3610. (Pubitemid 46630533)
    • (2006) Journal of Clinical Oncology , vol.24 , Issue.22 , pp. 3604-3610
    • Kalaycio, M.1    Rybicki, L.2    Pohlman, B.3    Sobecks, R.4    Andresen, S.5    Kuczkowski, E.6    Bolwell, B.7
  • 19
    • 2342524597 scopus 로고    scopus 로고
    • Predictive factors for successful stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine [7]
    • DOI 10.1038/sj.leu.2403326
    • Morgan SJ, Seymour JF, Grigg A, Matthews JP, Prince HM, Wolf MM et al. Predictive factors for successful stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine. Leukemia 2004; 18: 1034-1038. (Pubitemid 38714635)
    • (2004) Leukemia , vol.18 , Issue.5 , pp. 1034-1038
    • Morgan, S.J.1    Seymour, J.F.2    Grigg, A.3    Matthews, J.P.4    Prince, H.M.5    Wolf, M.M.6    Januszewicz, E.H.7
  • 22
    • 33745174485 scopus 로고    scopus 로고
    • High incidence of therapy-related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent lymphoproliferative disorders [4]
    • DOI 10.1111/j.1365-2141.2006.06158.x
    • Bowcock SJ, Rassam SM, Lim Z, Ward SM, Ryali MM, Mufti GJ. High incidence of therapy-related myelodysplasia and acute leukemia in general hematology clinic patients treated with fludarabine and cyclophosphamide for indolent lympho-proliferative disorders. Br J Haematol 2006; 134: 242-243. (Pubitemid 43893921)
    • (2006) British Journal of Haematology , vol.134 , Issue.2 , pp. 242-243
    • Bowcock, S.J.1    Rassam, S.M.B.2    Lim, Z.3    Ward, S.M.4    Ryali, M.M.5    Mufti, G.J.6
  • 23
    • 0035179950 scopus 로고    scopus 로고
    • DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine
    • Yamauchi T, Nowak BJ, Keating MJ, Plunkett W. DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludara-bine and clofarabine. Clin Cancer Res 2001; 7: 3580-3589. (Pubitemid 33069998)
    • (2001) Clinical Cancer Research , vol.7 , Issue.11 , pp. 3580-3589
    • Yamauchi, T.1    Nowak, B.J.2    Keating, M.J.3    Plunkett, W.4
  • 24
    • 0036659926 scopus 로고    scopus 로고
    • Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: Protective effect of defibrotide
    • DOI 10.1182/blood.V100.1.334
    • Eissner G, Multhoff G, Gerbitz A, Kirchner S, Bauer S, Haffner S et al. Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide. Blood 2002; 100: 334-340. (Pubitemid 35177465)
    • (2002) Blood , vol.100 , Issue.1 , pp. 334-340
    • Eissner, G.1    Multhoff, G.2    Gerbitz, A.3    Kirchner, S.4    Bauer, S.5    Haffner, S.6    Sondermann, D.7    Andreesen, R.8    Holler, E.9
  • 25
    • 56249094143 scopus 로고    scopus 로고
    • Preferential sensitivity of hematopoietic (HPs) and mesenchymal (MPs) progenitors to fludarabine suggests impaired bone marrow niche and HP mobilization
    • Berger MG, Berger J, Richard C, Jeanpierre S, Nicolini FE, Tournilhac O et al. Preferential sensitivity of hematopoietic (HPs) and mesenchymal (MPs) progenitors to fludarabine suggests impaired bone marrow niche and HP mobilization. Leukemia 2008; 22: 2131-2134.
    • (2008) Leukemia , vol.22 , pp. 2131-2134
    • Berger, M.G.1    Berger, J.2    Richard, C.3    Jeanpierre, S.4    Nicolini, F.E.5    Tournilhac, O.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.